Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.
Capital expenditures decreased by 84% from FY24 to FY25.
Current Price
$74.81
+1.81%Arrowhead Pharmaceuticals Inc (ARWR) Stock Chart
ARWR Interactive Stock Chart
Interactive stock chart for Arrowhead Pharmaceuticals Inc (ARWR) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.
Current price: $74.81. 52-week high: $74.81. 52-week low: $13.03. 50-day moving average: $63.74. 200-day moving average: $48.58.
Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for ARWR. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of Arrowhead Pharmaceuticals Inc's investment potential.